By expenditures
| Name | Title | Type |
|---|---|---|
| Mike Weaver | SUPERINTENDENT | Auditee |
| Jason Hohulin | Shareholder | Auditee |
| Brian Dukes | SUPERNTENDENT | Auditee |
| Richard W Phillips | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 361247 | 2024 | 2025-07-01 | Phillips and Associates CPAS PC | $2.30M |
| 304371 | 2023 | 2024-04-24 | Gorenz and Associates LTD | $3.57M |
| 31057 | 2022 | 2023-02-21 | Gorenz and Associates LTD | $3.50M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 304371 | 2023 | 2024-04-24 | 970812 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970811 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970810 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970809 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970808 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970807 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970806 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 970805 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394370 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394369 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394368 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394367 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394366 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394365 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394364 | 2023-002 | Significant Deficiency | Yes | C |
| 304371 | 2023 | 2024-04-24 | 394363 | 2023-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606703 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606702 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606701 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606700 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606699 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606698 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606697 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606696 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606695 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 606694 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30261 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30260 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30259 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30258 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30257 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30256 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30255 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30254 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30253 | 2022-002 | Significant Deficiency | Yes | C |
| 31057 | 2022 | 2023-02-21 | 30252 | 2022-002 | Significant Deficiency | Yes | C |